Prostate Cancer Clinical Trial: AMPLIFY

25 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
For more info, visit: https://www.primrmed.com/cancer-clinical-trials/amplify-trial

The AMPLIFY trial is evaluating the effectiveness of a new PSMA PET tracer, 64Cu-SAR-bisPSMA, in detecting prostate cancer recurrence in patients who have rising PSA levels after their initial cancer treatment, such as surgery, radiation, or other therapies.

This trial aims to improve the ability of doctors to locate areas where prostate cancer may have returned, leading to more accurate treatment plans and potentially better outcomes for patients with recurrent prostate cancer.

#prostatecancer
Categoria
Oncology
Commenta per primo questo video.

Prossimo